Health News and Scoops

Dallas, TX, May 21, 2012 –(PR.com)– The Centers for Medicare Medicaid Services issued a recent announcement expanding its definition of the medical staff, thereby allowing non-physician practitioners to have privileges similar to that of medical staff members. According to CMS officials, “We have broadened the concept of ‘medical staff’ and have allowed hospitals the flexibility to include other practitioners as eligible candidates for the medical staff with hospital privileges to practice in accordance with state law.” With these ground breaking changes, hospitals and healthcare systems have the opportunity to give non-physician practitioners, such as advanced practice nurses and physician assistants, the power to perform duties that they are trained for and allowed to do within their scope of practice and state law.

In light of the growing physician shortage, Nurse Practitioners and Physician Assistants can be utilized in a number of roles in both inpatient and outpatient settings to address primary care and sub-specialty issues, thereby allowing physicians to care for the chronically ill and medically complex patients that require more intense review. With the potential for advanced practice providers to discharge patients at the physician’s request, a recent New York State Health Foundation and Mathematica Policy Research found that improved discharge processes and post-discharge support can reduce readmission rates by 30-35 percent.

As the advanced practice role continues to evolve, Nurse Practitioners and Physician Assistants provide a concrete return on investment for hospitals, healthcare systems, mult-specialty providers, small physician groups and solo practitioners. Recognizing this unique need, Principle Healthcare Associates is pleased to announce the Nurse Practitioner, Physician Assistant, Health IT and Healthcare Executive Job Board. For a limited time, 90 day postings are being offered for $49 – act now in order to reach this in-demand population.

Media Contact
Jenifer Greenway
Principle Healthcare Associates
www.PrincipleHealthcareGroup.com

Article source: Read More

Cambridge, MA, May 21, 2012 –(PR.com)– Dossia, a leading health management system provider, today announced collaboration with leading stress/work-life expert Stephanie Marston, MFT, to offer 30 Days to Sanity™, an effective solution to help individuals reduce stress and improve the quality of their lives, work and relationships, to Dossia users. The 30 Days to Sanity™ solution helps people to effectively cope with the competing demands in their complicated, stress-filled lives. 30 Days to Sanity™ will now be available to Dossia users through the Marketplace in the Dossia Health Manager.

The capabilities that the 30 Days to Sanity™ solution now provides to Dossia users include:

· An interactive online program that provides strategies on how to reduce stress, increase productivity and make time for what truly matters

· Guided meditations and relaxations

· Parenting Center, offering parents resources and support

· Stress management content

· An online journal that allows users to track their progress

· A forum where users can connect with a community of other people who share similar goals, challenges and solutions

· A variety of other valuable resources

“Stress reduction is one of the key drivers in leading a happy, healthful life, and to helping individuals and families feel more empowered in managing their healthcare-related issues and challenges,” said Dossia CEO Mike Critelli. “Dossia is very pleased to be working with 30 Days to Sanity™ to bring these necessary resources to Dossia users.”

Stephanie Marston, MFT, the creator of 30 Days to Sanity™, has assisted Fortune 500 companies, global corporations, women’s and health-care organizations and professional associations in reducing employee stress, increasing productivity and creating a culture of satisfaction in the workplace. Additionally, she is one of the most sought-after experts in the country. Stephanie has conducted national and international seminars for more than 50,000 employees, corporate executives and women.

The Dossia Health Management System was launched in the summer of 2011, which included an extensive ecosystem of health applications for purchase in the Dossia Marketplace. The applications available in the Marketplace include a wide variety of services, ranging from stress reduction to health finance management. Dossia is dedicated to providing users with best in class solutions to help them manage their lives.

About Dossia
Dossia is a non-profit organization consisting of several large U.S. employers who have united under a common vision: to empower their employees to make smarter more informed decisions about their healthcare. Through Dossia, they will leverage their combined influence to break down barriers to health information, which will help drive consumer-initiated change. The Dossia Founders group includes ATT, Applied Materials, BP America, Cardinal Health, Intel, NantWorks, Pitney Bowes, sanofi-aventis, Vanguard Health Systems and Walmart. For more information, visit www.dossia.org.

About 30 Days to Sanity™
30 Days to Sanity™ the Emotional Well-Being Company is a media-based intervention company dedicated to using revolutionary technology to significantly improve peoples’ physical health and emotional well-being. Freedom from stress, anxiety, and depression – is the linchpin to individuals practicing healthy behavior. The result is reduced health related expenses and enhanced personal and organizational performance. 30 Days is currently being used by a number of Fortune 500 companies, healthcare organizations and government agencies with favorable business and health outcomes. 30 Days was founded by best selling author, and nationally recognized stress/work-life expert, Stephanie Marston, MFT. Ms. Marston has appeared frequently on shows such as; The Oprah Show, The Today Show, The Early Show and CNN Headline News. She is a licensed psychotherapist with decades of experience in stress management, depression, anxiety, and work-life issues. Ms. Marston is one of the most sought-after stress/well-being and productivity experts in the country.

Article source: Read More

Chapel Hill, NC, May 20, 2012 –(PR.com)– Source-Omega today announced their offerings for companies seeking security, freedom and a 5 year supply agreement in algae oil for price and quality improvements in times of change. “Why fear when I am here,” Says Dr Scott Doughman, PhD, owner of Source-Omega, a supplier of DHA supplements and volume bulk algae oil in the USA.

Source-Omega products include bulk algae oils and manufactured products from Schizochytrium for powdered algae meals, powdered lipid-extracts and algae oils with 20-carbon and 22-carbon chain length omega-3 (n3) and omega-6 (n6) polyunsaturated fatty acids (PUFAs), and which are natural components of the algae meals and extracted algae oils, which may be refined and formulated into any natural or processed forms of triglycerides, phospholipids, ethyl-esters, free-fatty-acids, all of which may be specifically incorporated into a dietary supplement or similarly regulated finished supplement regulated under the U.S. Dietary Supplement Health and Education Act (“DSHEA”), as it may be amended from time to time (“Dietary Supplements”), and Medical Food supplements that would qualify under the U.S. Orphan Drug Act of 1988, as it may be amended from time to time (“Medical Foods”), and Prescription Prenatal Vitamin Formulations regulated by the FDA, as it may be amended from time to time (“Prenatal Vitamins”), i.e. food supplements used for human and animal consumption for dietary, medical and/or veterinary use (individually and collectively, “Source-Omega Products”).

Dr Scott Doughman, Founder and CEO of Source-Omega, said he was asked recently what are their Terms and Conditions for buyers and whether Infant Formula will be part of their Class 1 filings for SOURCE OIL™. “First of all we are grateful to be able to offer a best-in-class choice. We are winning in leadership value and care for the Public Health. We offer the best of the best; the sole algae oil omega-3 from a water extracted process and we use only pure ingredients such as green tea polyphenols as antioxidant for both superior science and in terms of our global human values. Our business model upholds our collective duty to develop the omega-3 knowledge, reliable science and it’s uses for promoting peace, love, truth, right action and non-violence around the world. It concerns me when our competition uses words like ‘war’ and ‘penetration’ and ‘acceptance of Americans’ in the pejorative. I love algae oil. That is what people need to know. As an Infant Formula product, our oil will also be superior in formulation as far more closely matched to human breast milk composition than any other oil on the planet. Why not suggest Infant Formula? We do, and this is coming out after our first-to-draft patents are filed, when the time is right. Our oil refinement model is being organized to maintain price leadership.”

About: SOURCE-OMEGA, LLC is one of the leading algae DHA innovators for ‘Purity’ in all-vegetarian plant-based marine omega-3s. The company uses Schizochytrium micro-algae that undergoes a water extraction process to obtain the oil. The SOURCE OIL food category is defined as algae oil, non-hexane extracted.

Article source: Read More

Coral Springs, FL, May 20, 2012 –(PR.com)– MD Now Urgent Care is opening in Coral Springs near Parkland, Florida located at the Waterway Shoppes at Heron Bay at 6240 Coral Ridge Drive, just north of Sawgrass Expressway and near the city of Parkland on Monday May 21st 2012.

MD Now Urgent Care Coral Springs took over the site of the previous Imed Urgent Care, and undertook a complete and major remodeling of the facilities to bring it up to our MD Now standards.

“We look forward to meeting the high demand for our much needed state of the art and physician directed Urgent Care services in these two communities,” says Peter Lamelas, MD, MBA, CEO and Medical Director.

MD Now Urgent Care is open every day providing full-service, walk-in urgent care services, acute and episodic primary care, occupational medicine, as well as comprehensive healthcare services with procedure rooms, digital X-Ray and on-site lab testing.

Instead of waiting hours and spending thousands of dollars in an Emergency room or waiting days for a routine doctor’s appointment patients can expect, convenient friendly, fast and affordable medical care for “life’s little emergencies,” and most non-life threatening injuries and illnesses, in a safe and private environment.

MD Now’s state-of-the-art medical centers are open 12 hours a day, seven days a week, evening’s weekends and all holidays, most major types of health insurance are accepted but not required. They are always staffed by an on-site, licensed physician supported by a full medical team. MD Now Centers are state licensed Urgent Care Centers, accredited as well as designated as one of the few Certified Urgent Care Centers in Florida by the Urgent Care Association of America.

www.MyMDNow.com

Article source: Read More

Westborough, MA, May 18, 2012 –(PR.com)– Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is delighted to be a silver sponsor for the 2nd annual USP 797 Compliance Study. The 2012 study will run from May 1 – June 30, collecting survey data from facilities engaged in sterile compounding across the United States. As the largest and most comprehensive study of 797 compliance, the study effectively raises awareness of 797 standards and spotlights areas of non-compliance. In addition, study participants receive a confidential, complimentary gap analysis based on their survey entries. The gap analysis and accompanying action plan are designed to help remove some of the uncertainty that can occur when formulating an approach towards USP 797 compliance.

“Ameridose is dedicated to being a leader in sterile compounding practices,” affirmed Sophia Pasedis, PharmD and Vice President of Regulatory Affairs and Compliance for Ameridose. “The USP 797 gap analysis tool offers pharmacists a quick and convenient way to understand their compliance situation. We are truly excited to support this study and, in so doing, to help our clients.”

Facilities that conduct sterile compounding are invited to participate in the study from May 1 to June 30, 2012 at www.797study.com using survey code B797F.

The 2012 USP 797 Compliance Study is overseen by CriticalPoint and Study Directors, Eric Kastango and Kate Douglass. Study results and analysis will be published in Pharmacy Purchasing Products in October of 2012.

About Ameridose, LLC
Ameridose (www.Ameridose.com) is the leading provider of high quality sterile admixed and repackaged preparations and oral repackaging services to hospital pharmacies nationwide. Ameridose, an FDA registered manufacturer, exceeds USP 797 standards and meets cGMP requirements. Committed to delivering the finest outsourcing services in the industry, Ameridose considers quality, exceptional customer service, and value to be central elements of its corporate mission.

Article source: Read More